Target intelligence / Profile preview

Solitary chemosensory cell receptor (nasal) (None established; sometimes abbreviated as SCC receptor in literature, but not standardized.)

Target
None established; sometimes abbreviated as SCC receptor in literature, but not standardized.
Molecular classification
G protein-coupled receptor (for T2Rs), Receptor, Sensory transduction molecule
01

Overview

Nasal solitary chemosensory cells express a repertoire of G protein-coupled “bitter” taste receptors known as type II taste receptors (T2Rs), along with associated signaling proteins like α-gustducin and TRPM5 ion channels. These specialized epithelial sentinel cells extend processes into the mucus layer lining the anterior nasal cavity where they detect potentially harmful substances—including bacterial quorum-sensing molecules, environmental toxins/irritants like denatonium benzoate (“bitter”), cycloheximide, menthol—and trigger rapid protective responses by activating nearby trigeminal nerve fibers. This system provides an early warning mechanism against inhaled threats that may not penetrate deeply enough into tissue to reach traditional nociceptive neurons directly; instead it expands the range of detectable airborne dangers by sampling the surface environment above tight junction barriers within the epithelium. Dysfunction may contribute to increased susceptibility toward respiratory infections or inflammatory conditions.

Other names
Solitary chemoreceptor cellSolitary chemosensory cell (SCC)Nasal SCCBrush cell (sometimes used interchangeably but not always accurate)Trigeminal nociceptor-associated epithelial cells
02

Mechanism of action

Drugs/compounds that activate these receptors typically: Bind T2R “bitter” taste GPCRs on SCCs. Trigger intracellular signaling cascades involving α-gustducin G protein, PLCβ2 activation, calcium influx via TRPM5 channels. Resulting signals activate trigeminal nerve endings leading to protective reflexes such as sneezing or altered breathing patterns.

03

Biological functions

Detection of inhaled irritants and harmful chemicalsInitiation of respiratory-protective reflexes such as sneezing, apnea, or avoidance behaviorActivation of local immune responses and inflammation in response to pathogens or toxins
04

Disease associations

Inflammation (e.g., rhinitis)Infection defense/respiratory infection susceptibilityOther airway diseases related to impaired mucosal defense
05

Safety considerations

No direct safety concerns from targeting these molecules have been reported since no drugs are approved for this purpose.Non-specific activation leading to excessive inflammation or discomfort.Difficulty delivering therapeutics specifically to these rare epithelial cells without affecting other tissues expressing similar GPCRs.
06

Interacting drugs

No approved drugs directly target nasal solitary chemosensory cell receptors for therapeutic purposes at this time.

5 more in the full profile.

07

Biomarkers

Expression levels of T2R family members in nasal epitheliumα-gustducin expression

Beyond the preview

Go deeper on Solitary chemosensory cell receptor (nasal) (None established; sometimes abbreviated as SCC receptor in literature, but not standardized.).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solitary chemosensory cell receptor (nasal) (None established; sometimes abbreviated as SCC receptor in literature, but not standardized.).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call